| Literature DB >> 34707659 |
Jiali Gong1, Caiping Hu2, Meizhen Chen1, Qian Cao1, Qiuping Li1.
Abstract
OBJECTIVE: High levels of self-efficacy (SE) in colorectal cancer (CRC) patients and/or caregivers enable patients to cope with cancer, reduce caregiver burden, and promote quality of life (QOL) in patients and caregivers alike. This review aims to (a) identify the SE theory sources covered by SE interventions or interventions, including targeting improved SE for CRC patients and/or caregivers, to guide future development of SE interventions; and (b) explore intervention effects based on SE theory through meta-analysis.Entities:
Year: 2021 PMID: 34707659 PMCID: PMC8545593 DOI: 10.1155/2021/4553613
Source DB: PubMed Journal: J Oncol ISSN: 1687-8450 Impact factor: 4.375
Figure 1The flow diagram identifying the literature.
Quality assessment of the included observational studies using the EPHPP tool.
| Reference | Selection bias | Design | Confounders | Blinding | Data collection | Dropouts | Quality rating |
|---|---|---|---|---|---|---|---|
| Anderson et al. [ | M | M | S | W | M | S | M |
| Bains et al. [ | W | M | S | M | S | S | M |
| Cramer et al. [ | M | S | M | M | M | M | M |
| Döking et al. [ | W | W | M | M | S | S | M |
| Gao and Wu [ | S | S | M | W | M | W | W |
| Gao et al. [ | W | S | M | W | M | W | W |
| Giesler et al. [ | S | S | M | W | S | S | M |
| Huang et al. [ | S | S | S | M | S | M | S |
| Kelleher et al. [ | M | S | M | M | S | M | M |
| Kim et al. [ | S | M | S | W | S | S | M |
| Lim et al. [ | M | S | M | W | M | S | M |
| Luo et al. [ | M | M | M | M | S | S | M |
| Reese et al. [ | W | M | M | S | S | M | M |
| Shepherd et al. [ | M | S | S | M | S | W | M |
| Teo et al. [ | M | S | M | W | M | M | M |
| Xu et al. [ | M | S | S | W | S | W | W |
| Zhang et al. [ | M | S | S | W | S | S | M |
| Zhang et al. [ | S | S | M | M | S | S | S |
Selection Bias. Strong: very likely to be representative of the target population and greater than 80% participation rate; moderate: somewhat likely to be representative of the target population and 60%–79% participation rate; weak: all other responses or not stated. Design. Strong: RCT and CCT; moderate: cohort analytic, case-control, cohort, or an interrupted time series; weak: all other designs or design not stated. Confounders. Strong: controlled for at least 80% of confounders; moderate: controlled for 60%–79% of confounders; weak: confounders not controlled for, or not stated. Blinding. Strong: blinding of outcome assessor and study participants to intervention status and/or research question; moderate: blinding of either outcome assessor or study participants; weak: outcome assessor and study participants are aware of intervention status and/or research question. Data Collection Methods. Strong: tools are valid and reliable; Moderate: tools are valid but reliability not described; Weak: no evidence of validity or reliability. Withdrawals and Dropouts: strong: follow-up rate of >80% of participants; moderate: follow-up rate of 60%–79% of participants; weak: follow-up rate of <60% of participants or withdrawals and dropouts not described. Quality Rating. S: strong; M: moderate; W: weak. Strong: if a study had no weak ratings and at least four strong ratings, then it would be considered strong. Moderate: if the study had fewer than four strong ratings and one weak rating, it would be rated moderate. Weak: if a study had two or more weak ratings, it would be considered weak.
Figure 2Summary of risk of bias.
Figure 3(a) Effect of interventions based on Bandura's self-efficacy theory. (b) Effect of interventions not based on Bandura's self-efficacy theory.